Long-Term Study of the Efficacy and Safety of Lansoprazole in the Treatment of Zollinger-Ellison and Other Acid Hypersecretors.
Phase of Trial: Phase IV
Latest Information Update: 29 Oct 2012
At a glance
- Drugs Lansoprazole (Primary)
- Indications Zollinger-Ellison syndrome
- Focus Therapeutic Use
- 21 Dec 2010 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 21 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.